In this article we underline the importance of the transcriptional control of dopaminergic receptors in animal behavior. In particular, genetically modified animals, for some retinoid receptors, show locomotor phenotypes which resemble those found in dopamine receptor mutants. The finding that the dopamine D2 receptor contains in its promoter sequences that are responsive to retinoids points to a possible role of these molecules in the establishment of neuropathological diseases.
The importance of dopaminergic transmission in brain functions has been appreciated for a long time. Indeed, devastating human diseases such as Parkinson's or schizophrenia have in common dysfunctions of the dopaminergic system. Parkinson's disease is caused by a strong reduction of dopamine levels, due to degeneration of dopaminergic neurons, while an increase in expression of dopamine receptors has been evoked in schizophrenia. The molecular events responsible for these diseases are still largely unknown, and they might be in part genetic, caused by inherited mutations in one or more genes. 1, 2 Dopamine exerts its physiological functions through binding to membrane receptors 3 which are members of the seven transmembrane domains G-protein coupled receptor family. Once activated by dopamine, these receptors stimulate the activity of G-proteins resulting in the production of cellular second messengers, which in turn activate a cascade of intracellular events finally leading to the specific modifications of gene expression and cellular responses to the stimulus. Thus, although there is clear evidence that dopaminergic neurons degenerate in Parkinson's disease, it is also conceivable that less drastic alterations of any component of the dopaminergic pathway could result in parkinsonianlike phenotypes. Indeed, knockout mice bearing mutations in the dopamine D2 receptor (D2R) gene exhibit a locomotor parkinsonian-like phenotype and pituitary tumors. 4, 5 These studies demonstrated the crucial importance of this receptor in the control of multiple physiological functions, and revealed that alteration of its expression might underlie some human pathologies. This led us to investigate the mechanisms that control the expression of the D2R gene at the transcriptional level.
The promoters of the two major dopamine receptor (D1 and D2 receptors, D1R and D2R) genes exhibit house-keeping characteristics. [6] [7] [8] The D2R promoter has been dissected 7, 8 and shown to lack TATA and CAAT boxes, while containing multiple SP1 binding sites. 7, 8 Thus, the D1R and D2R specific expression patterns must be, at least in part, temporally and spatially dictated by cell-specific transcription factors. Interestingly, we found a retinoic acid response element (RARE), 9 ,10 centered at position −68, in the 5Ј flanking promoter region of the dopamine D2 receptor gene 7, 8 and composed of repeated motifs closely related to the canonical RARE motifs 5Ј-PuG(G/T)TCA-3Ј. 10 This element also resembles vitamin D3 receptor response elements (VDRE) which raises the interesting possibility that vitamin D3 may affect certain dopaminergic target neurons and/or cells of the pituitary gland. The presence of a non-consensus RARE in the D2R gene may result in lower binding affinities for retinoid receptors. This might correspond to a regulatory mechanism aimed at attenuating the response to cognate ligands in vivo.
The pattern of expression of members of the two retinoic-acid receptor families, the RARs (␣, ␤ and ␥) and the RXRs (␣, ␤ and ␥), suggests that they could play an important role in the control of D2R expression in the striatum.
11,12 Therefore we analyzed the expression of dopamine receptors in RAR and/or RXR knock-out mice and found that D2R expression was strongly decreased in certain RAR/RXR compound mutants. 9, 13 RAR␤-RXR␤, RAR␤-RXR␥ and RXR␤-RXR␥ double null mutants, but not RAR␤ or RXR␥ single mutants reproducibly exhibited 40% and 30% reduction in striatal D1R and D2R expression, respectively, when compared to WT controls. This indicated for the first time the possible involvement of RA in adult CNS functions and the role of RAR/RXR heterodimers in transducing the retinoid signal in particular brain areas.
As dopamine signalling, which is predominantly mediated by D1R and D2R in the striatum, 3 is involved in the control of motor planning (voluntary movements), 4, 14 we looked for alteration of the dopaminergic system in the retinoid receptor mutant mice. Interestingly, we found significant locomotor defects in RAR␤, RXR␤ and RXR␥ single and compound mutants. 13 This, together with the strong expression of these nuclear receptors in the striatum suggested a possible functional interaction between the retinoids and the dopaminergic system. The reduction of D1R and D2R transcripts was particularly marked in the medio-ventral regions of the striatum, including the shell and the core of the nucleus accumbens, and the medio-dorsal part of the caudate putamen. In contrast, expression of these receptors persisted in lateral and dorso-lateral striatal regions (Figure 1 ). 13 The simultaneous reduction of both D1R and D2R transcripts in the same brain area indicates that the expression of these two genes could be, at least partially, controlled in a coordinated fashion. Cocaine is a psychomotor stimulant which increases synaptic dopamine concentration by inhibiting the activity of the dopamine transporter. Higher DA concentration results in an overstimulation of post-synaptic DA receptors which leads to a hyperlocomotor phenotype. In agreement with the observation of a reduced expression of D1 and D2 receptors in RAR/RXR compound mutants, no effect of cocaine was observed in these animals when they were compared to wild-type littermates. 13 These data clearly show, at the physiological level, an alteration of the dopaminergic pathway in retinoid receptor mutants.
As mentioned above, mutation of the D2R gene in the mouse results in a parkinsonian-like phenotype 4 and pituitary tumors. 5 It is well established that Parkinson's disease is generated by a strong reduction of dopamine levels. Our data raise the possibility that aberrant expression of dopaminergic receptors might also lead to neurological disorders. Thus, the transcriptional control exerted by retinoid receptors on dopamine receptors may elicit important physiological consequences on dopaminergic cells. Indeed, it has recently been shown that knockout of the nuclear related receptor 1 (NURR1) gene, a member of the nuclear receptor gene single family, generates animals devoid of mesencephalic dopaminergic neurons. 15, 16 It is tempting to speculate that alterations in retinoid signalling might be another element to take into account in establishing the etiology of diseases such as Parkinson's or schizophrenia.
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